IPP Bureau
Apollo launches its 76th hospital, boosts tech-led healthcare in India
By IPP Bureau - April 28, 2026
Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof
Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers
By IPP Bureau - April 28, 2026
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
Concept Medical unveils promising 3-year data for sirolimus balloon therapy
By IPP Bureau - April 28, 2026
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care
By IPP Bureau - April 28, 2026
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report
By IPP Bureau - April 28, 2026
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
.png "EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control")
EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control
By IPP Bureau - April 28, 2026
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
OMRON Healthcare to donate 3,000 blood pressure monitors globally for hypertension screening
By IPP Bureau - April 28, 2026
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
Stryker launches Trident II Hip System in India
By IPP Bureau - April 28, 2026
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
From losses to lift-off: Astec gains ground in Q4 FY26
By IPP Bureau - April 28, 2026
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Jagsonpal Pharma profit surges 31% in Q4
By IPP Bureau - April 28, 2026
Rs. 40 cr buyback, 200% dividend announced
BPL Medical launches Blood Glucose Meter 582 for faster, easier diabetes monitoring
By IPP Bureau - April 28, 2026
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business
By IPP Bureau - April 28, 2026
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
AKUMS launches Aztreonam-Avibactam injection to combat multidrug-resistant infections
By IPP Bureau - April 28, 2026
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
HyugaLife raises Rs 100 crore in Series A to boost AI personalisation and offline expansion
By IPP Bureau - April 28, 2026
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
By IPP Bureau - April 28, 2026
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
